[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370562-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-370562-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","nonhypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias","Nonhypermutator Cancers Access Driver Mutations Through Reversals in Germline Mutational Bias","","Cancer is an evolutionary disease driven by mutations arising in asexual somatic cells, where the mutation spectrum can shift and bias reversals may accelerate adaptation. Analyzing tumors from 20 tissues together with normal tissue and germline data shows that nonhypermutated tumors reverse germline mutation bias and display consistent spectra across tissues. These spectrum changes match hypoxia signatures and enable positive selection in cancer genes.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nonhypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias/370562/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nonhypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias/370562.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What evolutionary mechanism can bias reversals in mutation spectra enable in asexual cells?","Question",{"text":62,"@type":63},"Bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What do the results show about nonhypermutated tumors compared with hypermutated tumors?",{"text":67,"@type":63},"Nonhypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues, while hypermutated tumors acquire drivers differently through higher mutation rates.",{"name":69,"@type":60,"acceptedAnswer":70},"How are the mutation spectrum changes linked to cancer gene selection?",{"text":71,"@type":63},"Spectrum changes carry a hypoxia signature and facilitate positive selection in cancer genes.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},370562,1790752176,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Nonhypermutator Cancers Access Driver Mutations Through Reversals in Germline Mutational Bias  \nMarwaZ. Tuffaha  , 1 David Castellano  ,2 Claudia Serrano Colomé  ,3 Ryan N. Gutenkunst  ,2 Lindi M. Wahl  1, *  \n1Mathematics, Western University, London, ON, Canada N6A 5B7  \n2 Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721, USA  \n3Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain *Corresponding author: E-mail: [lwahl@uwo.ca](lwahl@uwo.ca).  \nAssociate editor: Weiwei Zhai  \nAbstract  \nCancer is an evolutionary disease driven by mutations in asexually reproducing somatic cells. In asexual microbes, bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations. By analyzing tumors from 20 tissues, along with normal tissue and the germline, we demonstrate this effect in cancer. Nonhypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues. These spectra changes carry the signature of hypoxia, and they facilitate positive selection in cancer genes. Hypermutated and nonhypermutated tumors thus acquire driver mutations differently: hypermutated tumors by higher mutation rates and nonhypermutated tumors by changing the mutation spectrum to reverse the germline mutation bias.  \nKeywords: cancer, mutation bias, mutation spectrum, hypermutator, positive selection, hypoxia  \nIntroduction  \nCancer is an evolutionary disease arising from DNA mutations that allow cells to proliferate ab- normally and invade other tissues (Brown et al. 2023) . During the asexual reproduction of normal somatic cells, de novo mutations accumulate through time, which increases cancer risk with age (Cancer Research UK 2024) . Cancer develops when mutations in specific genes or combinations of genes (so-called “cancer genes”) impair normal cell function by, for example, disabling the cell cycle checkpoints or activating signals which drive excessive cell division (National Cancer Institute 2021) .  \nFor both evolution within a tumor and evolution within a population of asexual organisms, the mutation rate is a key factor. In microbial evolution, lineages with an increased mutation rate (mutators) frequently emerge due to their improved access to rare beneficial mutations (Raynes and Sniegowski 2014). Along with increases in mutation rate, changes in mutation spectra also affect mutational supply (Storz et al. 2019; Gomez et al. 2020; Sane et al. 2023) . We previously demonstrated that the interaction between mutation rate and spectrum powerfully influences the evolutionary trajectory of asexual populations (Tuffaha et al. 2023) . Simply put, previously undersampled mutations may be reached by either making more mutations (mutation rate elevation, Fig. 1a), or by making different mutations (mutation spectrum change, Fig. 1b) . If mutations have historically occurred with some bias (undersampling some classes of mutations while oversampling others), reversing this bias affords access to mutations that were previously unlikely to have occurred, such as undersampled beneficial mutations (Sane et al. 2023) .  \nCancer is a set of diseases that have similar hallmarks (Hanahan 2022), but there are many differences between cancer types, including different mutational processes and rates (Alexandrov et al. 2020) . Tumors vary in mutational burden both within the same tissue (across patients) and between different tissues (Zhou et al. 2021) . Hypermutation is usually caused by DNA mismatch repair defects, whether inherited or acquired from somatic mutations, which is common in gastrointestinal cancers (Yuza et al. 2017) . Exposure to UV light also elevates mutation rates in skin cancers (Garibyanand Fisher 2010) . Thus, hypermutation is sometimes defined based on these etiologies rather than the exact number of mutations (Alexandrov et al. 2020) . There is d","cbCaieYgGC5r5I1Y","https://ap.wps.com/l/cbCaieYgGC5r5I1Y","pdf",1232654,12,"English","# Abstract\n# Introduction\n## Mutation rate and mutation spectrum\n## Hypermutation and its definitions\n## Mutational signatures across tissues and exposures\n# Publications and license information","[{\"question\":\"What evolutionary mechanism can bias reversals in mutation spectra enable in asexual cells?\",\"answer\":\"Bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations.\"},{\"question\":\"What do the results show about nonhypermutated tumors compared with hypermutated tumors?\",\"answer\":\"Nonhypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues, while hypermutated tumors acquire drivers differently through higher mutation rates.\"},{\"question\":\"How are the mutation spectrum changes linked to cancer gene selection?\",\"answer\":\"Spectrum changes carry a hypoxia signature and facilitate positive selection in cancer genes.\"}]","Nonhypermutator Cancers Access Driver Mutations Through Reversals in Germline Mutational Bias | PDF",1790189179,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68a5b3d3fb3038da515da318d5eb8105.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf719f1644d65a582180b16e963e2f76.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b71bcab5c8014d92f4c7318c43e87c87.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/242ac065b388e8472cb203aca63d7712.webp",980,1268]